Aurobindo Eyes 40% Rise in US Injectables Business in FY18
7 years, 1 month ago

Aurobindo Eyes 40% Rise in US Injectables Business in FY18

Live Mint  

Aurobindo Pharma's US injectables business is expected to grow at least 40% this financial year, driven by new launches and higher sales from existing products. The company's injectables business has been growing significantly over the last two-three years, with US injectable sales rising by 67% in FY16-17 and 39% in FY15-16. The company expects about seven to nine product approvals in the US each in the remaining two quarters of this year, contributing to its growth.

Mumbai Entertainment Business Science Law  injectable  report  pharma  rise  40  million  pressure  sales  quarter  business  company  eyes  injectables  fy18  grow  aurobindo

History of this topic

Aurobindo Pharma Q1 Results: Net profit rises 61.3% to ₹918 crore, revenue up 10.5% YoY
4 months, 1 week ago

Aurobindo Pharma Q1 Results: Net profit rises 61.3% to ₹918 crore, revenue up 10.5% YoY

Live Mint  

Aurobindo Pharma Q1 Results: Aurobindo Pharma released its April-June quarter results for fiscal 2024-25 on August 10, reporting a rise of 61.3 per cent in net profit at ₹918 crore, compared to ₹569 crore in the corresponding period last year. The pharma major's revenue from operations during the first quarter of current fiscal stood at ₹7,567 crore, registering a rise …

Large cap stock hits 52-week high after US FDA conducts inspection at subsidiary
1 year ago

Large cap stock hits 52-week high after US FDA conducts inspection at subsidiary

Live Mint  

Shares of Aurobindo Pharma were locked in at over four per cent upper circuit at ₹1,081.45 apiece on the BSE, hitting its new 52-week high mark on Wednesday, December 20. ‘’The US FDA had conducted an inspection at the Unit IV, a Formulation manufacturing facility, of APL Healthcare Limited, a wholly owned subsidiary of the Company, situated at Menakuru Village, …

Aurobindo Pharma share price rises more than 1% on regulatory clearance of plant
1 year, 1 month ago

Aurobindo Pharma share price rises more than 1% on regulatory clearance of plant

Live Mint  

The news on the successful Completion of US FDA Inspection at Unit I & III of Aurobindo Pharma Ltd lifted investor sentiments and the share prices gained of Aurobindo Pharma gained more than 1% in morning trades on Monday, on a day when benchmark indices were trading in red. Aurobindo Pharma in its filing on the exchanges said that United …

Aurobindo shares double on US show
1 year, 4 months ago

Aurobindo shares double on US show

Live Mint  

Aurobindo Pharma Ltd saw its stock prices more than double during the last few months, from 52-week lows of ₹397.20 on the National Stock Exchange on 3 February to 52-week highs of ₹887.70 on 14 August. The European operations, which is the second largest contributor to the company’s overall revenues and contribute more than a fourth to them, are expected …

Aurobindo Pharma Q3 net drops 18% to ₹491 crore
1 year, 10 months ago

Aurobindo Pharma Q3 net drops 18% to ₹491 crore

The Hindu  

Drugmaker Aurobindo Pharma’s consolidated net profit declined more than 18%, year-on-year, in the December quarter to ₹491 crore even as revenue from operations increased 6.7% to ₹6,407.1 crore. Revenue from formulations were 9.2% more at ₹5,452.5 crore on the back of an increase in the same range in the U.S market to ₹3,001.2 crore. Vice-Chairman and MD K. Nithyananda Reddy …

Aurobindo Pharma shares surge on Q2 earnings
4 years, 1 month ago

Aurobindo Pharma shares surge on Q2 earnings

Live Mint  

Shares of Aurobindo Pharma surged as much as 7% today after the company reported a 26% increase in consolidated net profit in the second quarter ended September. Aurobindo Pharma on Wednesday reported a 26% increase in consolidated net profit at ₹805.65 crore in the second quarter ended September. The company had posted a consolidated net profit of ₹639.53 crore in …

Discover Related